Alliancebernstein L.P. Ocular Therapeutix, Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 162,820 shares of OCUL stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

162,820

Previous 162,820 -0.0%

Holding current value

$1.38 Million

Previous $1.11 Million 27.22%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $243,054 - $502,890	57,870 Added 55.14%	162,820 $1.11 Million
Q1 2024 May 14, 2024	BUY	$3.85 - $10.93 $40,810 - $115,858	10,600 Added 11.23%	104,950 $955,000
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $18,055 - $28,980	5,750 Added 6.49%	94,350 $296,000
Q2 2023 Aug 15, 2023	SELL	$4.6 - $7.64 $22,540 - $37,436	-4,900 Reduced 5.24%	88,600 $457,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $18,531 - $31,311	7,100 Added 8.22%	93,500 $262,000
Q3 2022 Nov 15, 2022	SELL	$4.09 - $6.5 $21,677 - $34,450	-5,300 Reduced 5.78%	86,400 $359,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $14,748 - $25,578	4,900 Added 5.65%	91,700 $369,000
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $966 - $1,470	200 Added 0.23%	86,800 $430,000
Q1 2021 May 06, 2021	BUY	$15.82 - $22.11 $34,804 - $48,642	2,200 Added 2.61%	86,600 $1.42 Million
Q4 2020 Feb 08, 2021	BUY	$7.91 - $22.95 $31,640 - $91,800	4,000 Added 4.98%	84,400 $1.75 Million
Q2 2020 Aug 13, 2020	SELL	$4.67 - $8.95 $56,974 - $109,189	-12,200 Reduced 13.17%	80,400 $670,000
Q1 2020 May 14, 2020	BUY	$3.95 - $7.4 $137,065 - $256,780	34,700 Added 59.93%	92,600 $458,000
Q3 2019 Nov 14, 2019	SELL	$3.04 - $5.32 $13,984 - $24,472	-4,600 Reduced 7.36%	57,900 $176,000
Q2 2019 Aug 14, 2019	BUY	$2.46 - $4.52 $36,408 - $66,896	14,800 Added 31.03%	62,500 $275,000
Q1 2019 May 14, 2019	SELL	$3.51 - $4.77 $11,934 - $16,217	-3,400 Reduced 6.65%	47,700 $189,000
Q3 2018 Nov 08, 2018	BUY	$5.42 - $6.99 $22,222 - $28,659	4,100 Added 8.72%	51,100 $352,000
Q2 2018 Aug 13, 2018	BUY	$5.99 - $8.17 $15,574 - $21,242	2,600 Added 5.86%	47,000 $317,000
Q4 2017 Feb 13, 2018	BUY	$3.73 - $6.37 $10,071 - $17,199	2,700 Added 6.47%	44,400 $198,000
Q3 2017 Nov 13, 2017	BUY	$5.28 - $6.88 $220,176 - $286,896	41,700	41,700 $258,000

Others Institutions Holding OCUL

# of Institutions

171

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Ocular Therapeutix, Inc Transaction History